Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
[LLY] Eli Lilly and Co. - Short-Term Debt
Data updated 2023-Sep-10 (Sunday)Note: Detailed Statistics for Short-Term Debt in Balance Sheet for Eli Lilly and Co. [NYSE:LLY] with frequency distribution chart that analyze trends & history . Short-Term Debt & current portion of Long-Term Debt are owed by Company at the end of the period. View Balance Sheet for broader context
Share
Quarterly Short-Term Debt values for Eli Lilly and Co. are rounded to enhance readability
| 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sep | 2022-Jun | 2022-Mar | |
|---|---|---|---|---|---|---|
| Short-Term Debt | 662 M | 3 M | 1.5 B | 1.75 B | 2.12 B | 1.36 B |
| Sequential Quarter Growth | +21,966.7% | -99.8% | -14.0% | -17.8% | +56.5% | -11.8% |
| Quarter-on Quarter Growth | -68.8% | -99.8% | -2.4% | +11.6% | +19.3% | +27,020.0% |
Annual Short-Term Debt values for Eli Lilly and Co. are rounded to enhance readability
| 2022-Dec | 2022-Jan | 2021-Jan | 2020-Jan | 2019-Jan | 2018-Jan | |
|---|---|---|---|---|---|---|
| Short-Term Debt | 1.5 B | 1.54 B | 1.54 B | 9 M | 1.62 B | 1.1 B |
| Year-on-Year Growth | -2.4% | +0.0% | +16,988.9% | -99.4% | +47.1% | -43.1% |
| 2-yr CAGR | -1.2% | +1,207.4% | -2.6% | -91.0% | -8.5% | +1,244.1% |
| 3-yr CAGR | +450.4% | -1.7% | +11.8% | -83.3% | +542.9% | |
| 4-yr CAGR | -1.9% | +8.7% | -5.6% | +10.2% | ||
| 5-yr CAGR | +6.4% | -4.5% | +202.2% |
Frequency distribution of quarterly Short-Term Debt values from 2015-Sep-30 grouped into buckets. Latest Short-Term Debt value is 662 Million as of 2023-Jun-30
Subsequent stock performance post earnings date till next announcement for Eli Lilly and Co. mapped with quarterly Short-Term Debt values reported at that time. Most recent value denoted with star
Select frequency and calculation type for Short-Term Debt above for vertical axis in scatter chart. Additionally choose type of performance for horizontal axis
Bayesian (Conditional Probability) analysis for Eli Lilly and Co. with subsequent post-earnings performance given Short-Term Debt values. Analysis uses quarterly data and subsequent absolute performance. Most recent quarter is denoted with a star and corresponding partial performance is excluded from calculations
| Underperform (absolute perf.) | Outperform (absolute perf.) | |
|---|---|---|
| Short-Term Debt - Low | 47% | 53% |
| Short-Term Debt - Medium | 42% | 58% |
| Short-Term Debt - High | 71% | 29% |
| Short-Term Debt (Sequential growth %) - Low | 42% | 58% |
| Short-Term Debt (Sequential growth %) - Medium | 62% | 38% |
| Short-Term Debt (Sequential growth %) - High | 62% | 38% |
| Short-Term Debt (QoQ growth %) - Low | 46% | 54% |
| Short-Term Debt (QoQ growth %) - Medium | 46% | 54% |
| Short-Term Debt (QoQ growth %) - High | 68% | 32% |
Related to Eli Lilly and Co.
Information for Eli Lilly and Co.
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers Currently Viewing
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Dividend History : History of Dividend Yield
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Oct-24 on Google
SEC Reports : Quarterly reports around 2025-Oct-24 on SEC Edgar
Compare Eli Lilly and Co. with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Eli Lilly and Co.
Industry : Pharmaceuticals industry performance which includes Eli Lilly and Co.